Business
ARIUS Annual Meeting May 25, 2006
ARIUS Annual Meeting May 25, 2006.
About this update from Affinity Metals Corp
[{"type":"text","content":"\n\n\n\n\nTORONTO, May 19 /CNW/ - ARIUS Research Inc. (\"ARIUS\") (TSX-V: ARI), today\nannounced its Annual Meeting of Shareholders will be held at the\nTSX Conference Centre Gallery, 130 King Street West, Toronto, Ontario, Canada,\non Thursday, May 25, 2006 at 1:00 p.m. (Toronto time).\nARIUS will review progress to date, focusing on the achievements of 2005\nand present a synopsis of plans going forward. Members of the management team\nwill be available to answer questions on recent financing and business\ndevelopment events including the $26.2 million private placement, the\nlicensing deal with Genentech, Inc. and the research collaboration with Takeda\nPharmaceutical Company Limited.\nA live webcast of the meeting will be available on ARIUS' website at\nwww.ariusresearch.com and at www.newswire.ca. The webcast will be archived for\n12 months.\n\nAbout ARIUS Research\nARIUS Research Inc. is a biotechnology company dedicated to personalizing\ncancer therapy through the discovery and development of novel anticancer\nmonoclonal antibodies (MAbs). Established in 1999, ARIUS has built a\nproprietary technology platform, FunctionFIRST(TM), that rapidly identifies\npowerful MAbs targeting a variety of cancer indications. This antibody\ngeneration engine has enabled ARIUS to assemble a growing pipeline, which is\nused for commercial collaborations and in-house development. ARIUS has ongoing\npartnerships with key biotechnology and drug development companies. The\ncompany is listed on the TSX Venture Exchange under the symbol \"ARI\".\n\nThe TSX Venture Exchange has not reviewed and does not accept\nresponsibility for the adequacy or accuracy of this statement.\n\nForward-Looking Statement\nCertain statements in this news release constitute \"forward-looking\nstatements\" within the meaning of the Private Securities Litigation Reform Act\nof 1995, which involve known and unknown risks, uncertainties and other\nfactors that may cause our actual results to be materially different from any\nfuture results, performance or achievements expressed or implied by such\nstatements. Forward-looking statements in this release include, but are not\nlimited to, ARIUS successfully advancing its new product programs as well as\nlicensing opportunities. These statements are only predictions and actual\nevents or results may differ materially. Factors ...